Wise A, Carr I C, Milligan G
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.
Biochem J. 1997 Jul 1;325 ( Pt 1)(Pt 1):17-21. doi: 10.1042/bj3250017.
A fusion protein was generated between the porcine alpha2A-adrenoceptor and a pertussis-toxin-insensitive (Cys351-->Gly) variant of the alpha subunit of Gi1alpha by direct in-frame fusion of the N-terminus of the G-protein to the C-terminus of the receptor. The fusion protein could be transiently expressed to high levels in COS-7 cells. Addition of the alpha2-adrenoceptor agonist 5-bromo-N-(4,5-dihydro- 1H-imidazol-2-yl)-6-quinoxalinamine (UK14304) to membranes of pertussis-toxin-treated transfected cells resulted in a concentration-dependent stimulation of high-affinity GTPase activity. Vmax estimations for the GTPase activity demonstrated an induced catalytic-centre activity of 2.0+/-0.2 min-1 for Gi1alpha when the alpha2A-adrenoceptor was maximally stimulated by UK14304 with a Km for GTP of 0.37+/-0.07 microM. Co-expression of excess beta1gamma2 along with the alpha2A-adrenoceptor-Gi1alpha fusion protein resulted in greater maximal UK14304-induced stimulation of high-affinity GTPase activity (2.1+/-0.2-fold) without alteration in agonist EC50. These studies demonstrate the functionality of the fusion construct, its capacity to interact with betagamma complex and its utility in measuring agonist regulation of the catalytic-centre activity of GTP by a receptor-associated G-protein.
通过将G蛋白的N端与受体的C端直接读框融合,在猪α2A -肾上腺素能受体与Gi1α亚基的百日咳毒素不敏感(Cys351→Gly)变体之间产生了一种融合蛋白。该融合蛋白可在COS - 7细胞中瞬时高水平表达。向经百日咳毒素处理的转染细胞的膜中添加α2 -肾上腺素能受体激动剂5 -溴 - N -(4,5 -二氢 - 1H -咪唑 - 2 -基)-6 -喹喔啉胺(UK14304),导致高亲和力GTP酶活性呈浓度依赖性刺激。当α2A -肾上腺素能受体被UK14304最大程度刺激时,对GTP酶活性的Vmax估计显示Gi1α的诱导催化中心活性为2.0±0.2 min-1,GTP的Km为0.37±0.07μM。过量的β1γ2与α2A -肾上腺素能受体 - Gi1α融合蛋白共表达,导致UK14304诱导的高亲和力GTP酶活性的最大刺激作用更大(2.1±0.2倍),而激动剂EC50没有改变。这些研究证明了融合构建体的功能、其与βγ复合物相互作用的能力以及其在测量受体相关G蛋白对GTP催化中心活性的激动剂调节中的效用。